Depletion of FBXO7‐Rbfox2 axis inhibits GBM tumorigenesis and sensitizes GBM xenograft to chemotherapy, indicating a potential strategy for the treatment of GBM. This evidence concerns the gene FBXO7 and glioblastoma.